Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01938469 · ClinicalTrials.gov registry record · NA

Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery

A NA study of Obesity and Gastric Bypass Surgery, sponsored by St. Luke's-Roosevelt Hospital Center.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT01938469: Completed NA study of Obesity and Gastric Bypass Surgery, sponsored by St. Luke's-Roosevelt Hospital Center.

NCT01938469 is a NA study of Obesity and Gastric Bypass Surgery that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 33 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01938469, a NA study of Obesity and Gastric Bypass Surgery, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

Analyze the effect of meal pattern (meal number, frequency, and form) on satiety, gut peptides, insulin, and glucose levels in individuals before and 12-15 months after gastric bypass surgery (GBP).

Interventions

  • OTHER Liquid Meal
  • OTHER Solid Meal

Study Locations (1)

New York

  • St. Lukes- Roosevelt Hospital- New York Obesity Research Center - New York

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2010-09
Est. Completion 2014-07
Phase NA

What the finished NCT01938469 record still lists

NCT01938469 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Liquid Meal is the first listed.

NCT01938469 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01938469 about?

NCT01938469 is a clinical study titled "Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery". Analyze the effect of meal pattern (meal number, frequency, and form) on satiety, gut peptides, insulin, and glucose levels in individuals before and 12-15 months after gastric bypass surgery (GBP).

What is the current status of trial NCT01938469?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2010-09. Estimated completion is 2014-07.

What conditions does trial NCT01938469 study?

This clinical trial studies the following conditions: Obesity, Gastric Bypass Surgery.

What interventions are being tested in trial NCT01938469?

The interventions under investigation include: Liquid Meal (OTHER), Solid Meal (OTHER).

Who is sponsoring clinical trial NCT01938469?

This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01938469 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01938469's enrollment target sits among peer trials

33 834th of 1053 higher than 216 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01938469, the US trial registry maintained by the National Library of Medicine. NCT01938469 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.